参考文献
［1］Chiu RG，Mehta Al.Spinal Metastases.Jama.2020，323：2438.
［2］Macedo F，Ladeira K，Pinho F，et al.Bone Metastases：An Overview.Oncology reviews.2017，11：321.
［3］Kusumbe AP.Vascular niches for disseminated tumour cells in bone.J Bone Oncol.2016，5：112-116.
［4］Hensel J，Thalmann GN.Biology of Bone Metastases in Prostate Cancer.Urology.2016，92：6-13.
［5］Liede A，Jerzak KJ，Hernandez RK，et al.The incidence of bone metastasis after early-stage breast cancer in Canada.Breast cancer research and treatment.2016，156：587-595.
［6］Dougall WC，Holen I，González Suárez E.Targeting RANKL in metastasis.BoneKEy reports.2014，3：519.
［7］Rucci N，Sanità P，Delle Monache S，et al.Molecular pathogenesis of bone metastases in breast cancer：Proven and emerging therapeutic targets.World journal of clinical oncology.2014，5：335-347.
［8］Wang Y，Lei R，Zhuang X，et al.DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis.The Journal of clinical investigation.2014，124：1646-1659.
［9］Roato I.Bone metastases：When and how lung cancer interacts with bone.World journal of clinical oncology.2014，5：149-155.
［10］Nandana S，Chung LW.Prostate cancer progression and metastasis：potential regulatory pathways for therapeutic targeting.American journal of clinical and experimental urology.2014，2：92-101.
［11］Rahim F，Hajizamani S，Mortaz E，et al.Molecular regulation of bone marrow metastasis in prostate and breast cancer.Bone marrow research.2014，2014：405920.
［12］Buenrostro D，Park SI，Sterling JA.Dissecting the role of bone marrow stromal cells on bone metastases.BioMed research international.2014，2014：875305.
［13］Barcellos-Hoff MH，Lyden D，Wang TC.The evolution of the cancer niche during multistage carcinogenesis.Nat Rev Cancer.2013，13：511-518.
［14］Naxerova K，Jain RK.Using tumour phylogenetics to identify the roots of metastasis in humans.Nature reviews.Clinical oncology.2015，12：258-272.
［15］Gundem G，Van Loo P，Kremeyer B，et al.The evolutionary history of lethal metastatic prostate cancer.Nature.2015，520：353-357.
［16］Hosseini H，Obradovi
MMS，Hoffmann M，et al.Early dissemination seeds metastasis in breast cancer.Nature.2016，540：552-558.
［17］Harper KL，Sosa MS，Entenberg D，et al.Mechanism of early dissemination and metastasis in Her2（+）mammary cancer.Nature.2016，540：588-592.
［18］Bidwell BN，Slaney CY，Withana NP，et al.Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape.Nat Med.2012，18：1224-1231.
［19］Vogelstein B，Papadopoulos N，Velculescu VE，et al.Cancer genome landscapes.Science（New York，N.Y.）.2013，339：1546-1558.
［20］Baxter E，Windloch K，Gannon F，et al.Epigenetic regulation in cancer progression.Cell & bioscience.2014，4：45.
［21］Shi X，Tasdogan A，Huang F，et al.The abundance of metabolites related to protein methylation correlates with the metastatic capacity of human melanoma xenografts.Science advances.2017，3：eaao5268.
［22］Vanharanta S，Shu W，Brenet F，et al.Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer.Nat Med.2013，19：50-56.
［23］Peinado H，Zhang H，Matei IR，et al.Pre-metastatic niches：organ-specific homes for metastases.Nat Rev Cancer.2017，17：302-317.
［24］Zhuang X，Zhang H，Li X，et al.Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1.Nature cell biology.2017，19：1274-1285.
［25］Jung Y，Kim JK，Shiozawa Y，et al.Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.Nature communications.2013，4：1795.(https://www.daowen.com)
［26］Zhang XH，Jin X，Malladi S，et al.Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.Cell.2013，154：1060-1073.
［27］Graham N，Qian BZ.Mesenchymal Stromal Cells：Emerging Roles in Bone Metastasis.International journal of molecular sciences.2018，19.
［28］Crane GM，Jeffery E，Morrison SJ.Adult haematopoietic stem cell niches.Nature reviews.Immunology.2017，17：573-590.
［29］Wang H，Yu C，Gao X，et al.The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.Cancer cell.2015，27：193-210.
［30］Kwakwa KA，Sterling JA.Integrin αvβ3 Signaling in Tumor-Induced Bone Disease.Cancers.2017，9.
［31］Ghajar CM，Peinado H，Mori H，et al.The perivascular niche regulates breast tumour dormancy.Nature cell biology.2013，15：807-817.
［32］Pan H，Gray R，Braybrooke J，et al.20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.N Engl J Med.2017，377：1836-1846.
［33］Bragado P，Estrada Y，Parikh F，et al.TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling.Nature cell biology.2013，15：1351-1361.
［34］Yu-Lee LY，Yu G，Lee YC，et al.Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.Cancer research.2018，78：2911-2924.
［35］Esposito M，Mondal N，Greco TM，et al.Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis.Nature cell biology.2019，21：627-639.
［36］Sosa MS，Parikh F，Maia AG，et al.NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes.Nature communications.2015，6：6170.
［37］Sosa MS，Bragado P，Aguirre-Ghiso JA.Mechanisms of disseminated cancer cell dormancy：an awakening field.Nat Rev Cancer.2014，14：611-622.
［38］Gawrzak S，Rinaldi L，Gregorio S，et al.MSK1 regulates luminal cell differentiation and metastatic dormancy in ER（+）breast cancer.Nature cell biology.2018，20：211-221.
［39］Shiozawa Y，Pedersen EA，Patel LR，et al.GAS6/AXL axis regulates prostate cancer invasion，proliferation，and survival in the bone marrow niche.Neoplasia（New York，N.Y.）.2010，12：116-127.
［40］Yumoto K，Eber MR，Wang J，et al.Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.Scientific reports.2016，6：36520.
［41］Cackowski FC，Eber MR，Rhee J，et al.Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.Journal of cellular biochemistry.2017，118：891-902.
［42］Wang N，Docherty F，Brown HK，et al.Mitotic quiescence，but not unique“stemness，”marks the phenotype of bone metastasis-initiating cells in prostate cancer.FASEB journal：official publication of the Federation of American Societies for Experimental Biology.2015，29：3141-3150.
［43］Kakonen SM，Selander KS，Chirgwin JM，et al.Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways.The Journal of biological chemistry.2002，277：24571-24578.
［44］Ottewell PD.The role of osteoblasts in bone metastasis.J Bone Oncol.2016，5：124-127.
［45］Guise TA，Yin JJ，Taylor SD，et al.Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.The Journal of clinical investigation.1996，98：1544-1549.
［46］Johnson RW，Finger EC，Olcina MM，et al.Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.Nature cell biology.2016，18：1078-1089.
［47］Johnson RW，Sun Y，Ho PWM，et al.Parathyroid Hormone-Related Protein Negatively Regulates Tumor Cell Dormancy Genes in a PTHR1/Cyclic AMP-Independent Manner.Frontiers in endocrinology.2018，9：241.
［48］Lu X，Mu E，Wei Y，et al.VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.Cancer cell.2011，20：701-714.
［49］Luo X，Fu Y，Loza AJ，et al.Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development.Cell reports.2016，14：82-92.
［50］Ottewell PD，Wang N，Brown HK，et al.OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone.International journal of cancer.2015，137：968-977.